Viewpoints: Obama Needs To Lead On Cures Act; Pricing Drugs To Value; Preventing Alzheimer’s
A selection of opinions on health care from around the country.
The independent source for health policy research, polling, and news.
36,141 - 36,160 of 112,624 Results
A selection of opinions on health care from around the country.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Outlets report on health news from Texas, New Jersey, Virginia, Pennsylvania, Minnesota, Florida, Ohio, Connecticut, Wisconsin and Tennessee.
The state's Medicaid program allows coverage for the medications to enrollees only with the most advanced stages of liver disease. News outlets also report on Medicaid developments in Alabama and Arkansas.
Under federal law, companies must fully insure and fund their pension plans, but religious organizations are exempted from the requirements. Dignity Health and some other faith-based organizations are seeking a similar exemption, but dozens of lawsuits from employee groups have been filed. Also, news about hospital mergers, initiatives and studies.
Other public health developments related to good gut bacteria, treating breast cancer in pregnant women, Legionnaires’ disease outbreaks and the Mark Zuckerberg disease initiative make headlines.
The struggles that come with treating an addiction are amplified for women who have children. Meanwhile, discarded drug needles that litter Methadone Mile in Boston paint the picture of heroin and opioid abuse in the city, two are indicted in Ohio for dealing drugs laced with an animal tranquilizer and more news about the opioid crisis.
"I did it because there was a cultural attitude I was immersed in: You viewed all attorneys as a threat and anything that you did was OK to thwart their efforts to sue your colleagues," Dr. Lars Aanning says in an interview with ProPublica. Aanning broke his silence over what he'd done decades earlier partly to give an explicit example of why physician testimony can't be trusted in court.
Crispr-Cas9 is embroiled in a high-stakes patent dispute for control over groundbreaking technology that can cut DNA and make repairs or changes to genes. But that hasn't stopped companies from launching development programs that would use the tool.
The lawsuit claims that Indivior persuaded the FDA to approve a dissolvable strip version of their drug by raising concerns that the tablet posed high exposure risks to children. Even though the agency rejected the claims, by the time the generics hit the marketplace, many patients had already switched over.
Sliding in just below 10 percent lets pharmaceutical companies fly under the radar of regulators watching for double-digit increases. In other industry news, companies are freeze-drying drugs for long-distance transport, Rite Aid's sales come in below expectations and new drugs may hold the key to treating migraines.
Senate Majority Leader Mitch McConnell unveiled a measure that includes $1.1 billion in funding for Zika, but Democrats immediately rejected the bill because it lacks money to address the Flint water crisis.
Republicans became worried after a Sept. 9 memo on 2015 risk corridor payments showed that HHS was open to discussing resolution of the lawsuits from insurers. The program was designed to help insurers that suffer losses on the ACA exchanges by giving them payments from other insurers that did well on the new business.
The Commonwealth Fund study also found that 9 million would gain coverage under Hillary Clinton's proposals.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Outlets report on health news from Florida, Minnesota, California and Tennessee.
The state audit found that nearly 35,000 applications were still pending last month. But legislative auditors tell lawmakers that they can't verify the numbers in the state audit because they are generated by a private contractor and have been wrong before.
Both states ban Medicaid funding of any group that also provides abortions, but the cases are being argued in the shadow of a recent decision by the 5th Circuit Court of Appeals to uphold an injunction against a similar Louisiana law.
© 2026 KFF